H.C. Wainwright analyst Robert Burns raised the firm’s price target on Exelixis to $29 from $28 and keeps a Buy rating on the shares following the Q2 report.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Closing Bell Movers: Airbnb, TripAdvisor down double digits on earnings
- Exelixis sees FY24 revenue $1.975B-$2.075B, consensus $1.88B
- Exelixis announces additional $500M share buyback program through 2025-end
- Exelixis reports Q2 EPS 85c, consensus 30c
- Exelixis announces cabozantinib sNDA accepted by FDA
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue